Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MW-189 by ImmunoChem Therapeutics for Intracerebral Hemorrhage: Likelihood of Approval
MW-189 is under clinical development by ImmunoChem Therapeutics and currently in Phase II for Intracerebral Hemorrhage. According to GlobalData, Phase...